Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P33
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -37.50% |
| Q3 2025 | 47.74% |
| Q2 2025 | 1.47% |
| Q1 2025 | 20.86% |
| Q4 2024 | -51.60% |
| Q3 2024 | -13.24% |
| Q2 2024 | 24.99% |
| Q1 2024 | 131.69% |
| Q4 2023 | -62.91% |
| Q3 2023 | 17.13% |
| Q2 2023 | 36.01% |
| Q1 2023 | 165.22% |
| Q4 2022 | -25.27% |
| Q3 2022 | 623.80% |
| Q2 2022 | -94.45% |
| Q1 2022 | 25.53% |
| Q4 2021 | 1474.19% |
| Q3 2021 | -92.01% |
| Q2 2021 | 40.89% |
| Q1 2021 | 35.12% |
| Q4 2020 | 91.81% |
| Q3 2020 | -70.73% |
| Q2 2020 | 1937.17% |
| Q1 2020 | -73.87% |
| Q4 2019 | 147.09% |
| Q3 2019 | -123.21% |
| Q2 2019 | 1532.77% |
| Q1 2019 | -137.93% |
| Q4 2018 | -39.69% |
| Q3 2018 | 248.14% |
| Q2 2018 | -45.78% |
| Q1 2018 | -14.39% |
| Q4 2017 | 295.02% |
| Q3 2017 | -45.96% |
| Q2 2017 | -79.58% |
| Q1 2017 | 59.92% |
| Q4 2016 | 979.04% |
| Q3 2016 | -86.08% |
| Q2 2016 | -33.05% |
| Q1 2016 | 323.79% |